Clinical Data With Lurbinectedin in Small Cell Lung Cancer
Key opinion leaders share a focused discussion on lurbinectedin and its evolving role in small cell lung cancer following frontline therapy.
EP: 1.Current Strategies in Diagnosis and Classification of Small Cell Lung Cancer
EP: 2.Small Cell Lung Cancer: What is the Role of Biomarker Testing?
EP: 3.Real-World Data and Observed AEs With Frontline Chemo IO Therapy in SCLC
EP: 4.Novel and Emerging Frontline Treatment Strategies in SCLC
EP: 5.Overview of Frontline Treatment Options in Small Cell Lung Cancer
EP: 6.Small Cell Lung Cancer: What is the Role of IO Therapy in the Frontline Setting?
EP: 7.Overview of Second-Line Treatment Options in SCLC
Now Viewing
EP: 8.Clinical Data With Lurbinectedin in Small Cell Lung Cancer
EP: 9.The Evolving Treatment Landscape of Small Cell Lung Cancer
Related Videos
Related Content
